Cargando…
Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence
BACKGROUND: Flexible dosing of anticholinergics used for overactive bladder (OAB) treatment is a useful strategy in clinical practice for achieving a maximum effective and maximum tolerated level of therapeutic benefit. In this post hoc analysis we evaluated the efficacy and tolerability of trospium...
Autores principales: | Bödeker, Rolf-Hasso, Madersbacher, Helmut, Neumeister, Claudia, Zellner, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945343/ https://www.ncbi.nlm.nih.gov/pubmed/20840754 http://dx.doi.org/10.1186/1471-2490-10-15 |
Ejemplares similares
-
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
por: Guay, David RP
Publicado: (2005) -
Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study
por: Ivchenko, A., et al.
Publicado: (2018) -
Brain penetration of the OAB drug trospium chloride is not increased in aged mice
por: Kranz, Jasmin, et al.
Publicado: (2011) -
Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany
por: Murgas, Sandra, et al.
Publicado: (2019) -
Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)